Over one-third of refractory lupus patients remain stable at long term follow-up

Lupus :: Over one-third of refractory lupus patients remain stable at long term follow-up

Thirty-six percent of patients with refractory systemic lupus erythematosus remain well after undergoing B-cell depletion therapy without needing further standard immunosuppressive agents, according to a study presented today at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain.

Overactive B-cells are commonly found in patients with SLE and reducing the number of B-cells in the system by BCDT has been suggested as a promising therapy for SLE patients who are unresponsive to other treatments.

In this study, initiated in 2000, patients with refractory SLE were treated with BCDT (based on rituximab) using a combination protocol with cyclophosphamide and steroids. Of the 33 patients who had a minimum of 6 months follow-up duration at the time of analysis (mean duration 37 months, range 6-79), 12 patients remained well. Median duration of B-cell depletion was 4 months (range 2-15), with 2 patients remaining depleted at time of analysis (73 and 8 months respectively). B-cell depletion was beneficial clinically, with a decrease of median global BILAG scores (clinical activity index ? see Editors note) from 13 to 5 when measured between 5 and 8 months p




(Lupus :: Over one-third of refractory lupus patients remain stable at long term follow-up published at SpiritIndia on Thursday, June 14, 2007)

Lupus

Search more information on Lupus, Lupus books

Recently posted related articles on Lupus :

1. Lupus :: Immunosuppressive drug effective for reducing lupus flares
2. Lupus :: Research suggests targeted treatment strategies for lupus
3. Lupus :: Existing drugs show promise for treating end-stage renal disease in lupus
4. Lupus :: Patients, Physicians Invited to Lupus Education Day
5. Lupus :: Gene linked to Lupus
6. Lupus :: Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Lupus :: Controlling stress helps fight chronic diseases such as lupus
8. Lupus :: Research links genetic mutations to lupus
9. Lupus :: Despite different triggers of disease, all roads lead to lupus
10. Sperm :: Sperm abnormalities seen in male lupus patients

Most related articles:

- Lupus :: Over one-third of refractory lupus patients remain stable at long term follow-up
- Lupus :: Gene linked to Lupus - 17.6
- Lupus :: Abnormal pap smears in women with lupus - 16.4
- Lupus :: Despite different triggers of disease, all roads lead to lupus - 15.3
- Systemic Lupus Erythematosus :: Interferon-regulated chemokines and SLE - 15.2
- Lupus :: Epigenetic code n patients with systemic lupus erythematosus - 13.7
- Lupus :: Bio-Tech Company Conquers Lupus - 13.7
- Lupus :: Genelabs for additional trial of lupus drug Prestara - 13.5
- Lupus :: Cancer Drug Rituximab Fights Lupus - 13.5
- Lupus :: Mirac stops the proliferation of cells that cause Lupus - 12.7

Lupus - recent related articles/news stories:

- Lupus drug Benlysta effective for SLE patients
- Genes linked with lupus giving hope for new treatments

»»   Rheumatoid Arthritis :: Gender disparity in anti-TNF treatment for rheumatoid arthritis
««   Osteoarthritis :: Aggressive nature of hand osteoarthritis

Home | Cancer | Therapies | Diet | Herbs | Heart | Skin | Cosmetic Surgery | Arthritis | Allergies | Eyes | GIT | Glossary | List

AYUSH = Ayurveda - Yoga - Unani - Siddha - Homeopathy -- Health articles

The information provided on SpiritIndia.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Spirit India comply with the HONcode principles for trustworthy health information.
Health, Business, Science, Sports, Entertainment, Technology
©2002-2009 SpiritIndia.com